A Study of Molidustat for Correction of Renal Anemia in Dialysis Subjects
Status:
Completed
Trial end date:
2018-11-20
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of Molidustat in dialysis
subjects with renal anemia who are not treated with Erythropoiesis-Stimulating Agents (ESAs)